Metagenomi Inc (NASDAQ: MGX) is -60.86% lower on its value in year-to-date trading and has touched a low of $1.23 and a high of $5.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MGX stock was last observed hovering at around $1.59 in the last trading session, with the day’s gains setting it 404.29%.
Currently trading at $405.88K, the stock is -6.80% and -8.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.61 million and changing 3613176% at the moment leaves the stock -32.10% off its SMA200. MGX registered -59.56% loss for a year compared to 6-month loss of -63.59%. The firm has a 50-day simple moving average (SMA 50) of $1.6001 and a 200-day simple moving average (SMA200) of $2.1501.
The stock witnessed a -11.52% gain in the last 1 month and extending the period to 3 months gives it a -5.19%, and is 0.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.23% over the week and 8.60% over the month.
Metagenomi Inc (MGX) has around 202 employees, a market worth around $54.58M and $45.26M in sales. Profit margin for the company is -172.21%. Distance from 52-week low is 18.70% and -73.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.99%).
The EPS is expected to shrink by -3.60% this year.
Metagenomi Inc (MGX) Top Institutional Holders
104.0 institutions hold shares in Metagenomi Inc (MGX), with institutional investors hold 36.90% of the company’s shares. The shares outstanding are 37.38M, and float is at 21.80M with Short Float at 9.61%. Institutions hold 26.49% of the Float.
The top institutional shareholder in the company is NOVO HOLDINGS A/S with over 1.8 million shares valued at $7.34 million. The investor’s holdings represent 4.9146% of the MGX Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 1.48 million shares valued at $6.03 million to account for 4.0348 of the shares outstanding. The other top investors are FARALLON CAPITAL MANAGEMENT LLC which holds 1.34 million shares representing 3.6674% and valued at over $5.48 million, while PFM HEALTH SCIENCES, LP holds 3.4594 of the shares totaling 1.27 million with a market value of $5.17 million.
Metagenomi Inc (MGX) Insider Activity
The most recent transaction is an insider sale by Wein Matthew. SEC filings show that Wein Matthew sold 199 shares of the company’s common stock on Jun 06 ’25 at a price of $1.75 per share for a total of $348.0. Following the sale, the insider now owns 16693.0 shares.
Metagenomi Inc disclosed in a document filed with the SEC on Jun 06 ’25 that Noonberg Sarah B. (Chief Medical Officer) sold a total of 5,239 shares of the company’s common stock. The trade occurred on Jun 06 ’25 and was made at $1.75 per share for $9168.0. Following the transaction, the insider now directly holds 0.11 million shares of the MGX stock.
Still, SEC filings show that on Jun 06 ’25, Wapnick Pamela (Chief Financial Officer) disposed off 1,576 shares at an average price of $1.75 for $2758.0. The insider now directly holds 72,108 shares of Metagenomi Inc (MGX).
